Probiotics Dietary Supplements Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others), By End-use (Infants, Children, Adults, Geriatric), By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others), By Region, & Competition, 2020-2030F
The Global Probiotics Dietary Supplements Market was valued at USD 8.76 billion in 2024 and is projected to achieve strong growth over the forecast period, with a compound annual growth rate (CAGR) of 10.75% through 2030.
The market is experiencing accelerated expansion, driven by a clear shift in consumer behavior toward scientifically validated and proactive approaches to health management. Probiotics—live microbial strains with clinically proven benefits for gut and immune health—are becoming an integral component of evidence-based nutritional strategies across a broad range of consumer demographics.
This growing adoption is closely tied to the increasing prevalence of lifestyle-related health conditions, including gastrointestinal disorders, weakened immune response, and chronic inflammation—particularly among adults and aging populations. Consumers are gravitating toward natural, non-pharmaceutical alternatives, fueling demand for probiotic products that align with clean-label principles and preventive wellness practices.
Key Market Drivers
Rising Prevalence of Gastrointestinal and Lifestyle-Related Disorders
The surge in gastrointestinal (GI) and lifestyle-related disorders is a key growth driver for the probiotics dietary supplements market. Non-communicable diseases (NCDs), which include many of these disorders, have become the dominant global health challenge, accounting for approximately 75% of all non-pandemic-related deaths. In 2021, NCDs were responsible for over 43 million deaths worldwide, with cardiovascular conditions leading the count.
This shift has influenced both consumer behavior and healthcare priorities, positioning probiotics as an essential element of preventive and therapeutic strategies focused on gut health and overall well-being. Digestive issues such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), acid reflux, constipation, and bloating are increasingly common across various age groups and geographies, further driving demand for probiotic supplementation.
Key Market Challenges
Quality Control and Product Standardization
Maintaining the quality, efficacy, and stability of probiotic supplements remains a significant challenge. As live microorganisms, probiotics must remain viable throughout the entire production, packaging, storage, and distribution cycle. Any degradation in potency can result in inconsistent health outcomes and potentially undermine consumer confidence. Ensuring stringent quality standards and formulation integrity is therefore critical for sustained market growth and credibility.
Key Market Trends
Emergence of Personalized Nutrition
The growing demand for individualized health solutions is reshaping the probiotics landscape. Personalized nutrition—including custom probiotic formulations—is gaining momentum as consumers increasingly seek products tailored to their unique physiological needs. Innovations such as DNA testing and microbiome analysis are enabling the identification of specific probiotic strains that deliver targeted benefits based on individual health profiles, paving the way for highly personalized and effective wellness interventions.
Key Market Players
In this report, the Global Probiotics Dietary Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Probiotics Dietary Supplements Market.
Available Customizations:
Global Probiotics Dietary Supplements market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
The market is experiencing accelerated expansion, driven by a clear shift in consumer behavior toward scientifically validated and proactive approaches to health management. Probiotics—live microbial strains with clinically proven benefits for gut and immune health—are becoming an integral component of evidence-based nutritional strategies across a broad range of consumer demographics.
This growing adoption is closely tied to the increasing prevalence of lifestyle-related health conditions, including gastrointestinal disorders, weakened immune response, and chronic inflammation—particularly among adults and aging populations. Consumers are gravitating toward natural, non-pharmaceutical alternatives, fueling demand for probiotic products that align with clean-label principles and preventive wellness practices.
Key Market Drivers
Rising Prevalence of Gastrointestinal and Lifestyle-Related Disorders
The surge in gastrointestinal (GI) and lifestyle-related disorders is a key growth driver for the probiotics dietary supplements market. Non-communicable diseases (NCDs), which include many of these disorders, have become the dominant global health challenge, accounting for approximately 75% of all non-pandemic-related deaths. In 2021, NCDs were responsible for over 43 million deaths worldwide, with cardiovascular conditions leading the count.
This shift has influenced both consumer behavior and healthcare priorities, positioning probiotics as an essential element of preventive and therapeutic strategies focused on gut health and overall well-being. Digestive issues such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), acid reflux, constipation, and bloating are increasingly common across various age groups and geographies, further driving demand for probiotic supplementation.
Key Market Challenges
Quality Control and Product Standardization
Maintaining the quality, efficacy, and stability of probiotic supplements remains a significant challenge. As live microorganisms, probiotics must remain viable throughout the entire production, packaging, storage, and distribution cycle. Any degradation in potency can result in inconsistent health outcomes and potentially undermine consumer confidence. Ensuring stringent quality standards and formulation integrity is therefore critical for sustained market growth and credibility.
Key Market Trends
Emergence of Personalized Nutrition
The growing demand for individualized health solutions is reshaping the probiotics landscape. Personalized nutrition—including custom probiotic formulations—is gaining momentum as consumers increasingly seek products tailored to their unique physiological needs. Innovations such as DNA testing and microbiome analysis are enabling the identification of specific probiotic strains that deliver targeted benefits based on individual health profiles, paving the way for highly personalized and effective wellness interventions.
Key Market Players
- Vitakem Nutraceutical Inc
- Lesaffre International Corp
- DuPont de Nemours Inc
- H&H Group PLC
- Amway Corp
- Abbott Laboratories Inc
- Bayer AG
- Pfizer Inc.
- GSK PLC
- BASF SE
In this report, the Global Probiotics Dietary Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Probiotics Dietary Supplements Market, By Form:
- Chewables & Gummies
- Capsules
- Powders
- Tablets & Softgels
- Others
- Probiotics Dietary Supplements Market, By End-Use:
- Infants
- Children
- Adults
- Geriatric
- Probiotics Dietary Supplements Market, By Application:
- Sports Fitness
- Energy & Weight Management
- General Health
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Skin/Hair/Nails
- Brain/Mental Health
- Others
- Probiotics Dietary Supplements Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Company Profiles: Detailed analysis of the major companies present in the Global Probiotics Dietary Supplements Market.
Available Customizations:
Global Probiotics Dietary Supplements market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
5.2.2. By End-use (Infants, Children, Adults, Geriatric)
5.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Product Market Map
6. NORTH AMERICA PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
6.2.2. By End-use (Infants, Children, Adults, Geriatric)
6.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Probiotics Dietary Supplements Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Form
6.3.1.2.2. By End-use
6.3.1.2.3. By Applications
6.3.2. Canada Probiotics Dietary Supplements Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Form
6.3.2.2.2. By End-use
6.3.2.2.3. By Applications
6.3.3. Mexico Probiotics Dietary Supplements Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Form
6.3.3.2.2. By End-use
6.3.3.2.3. By Applications
7. EUROPE PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
7.2.2. By End-use (Infants, Children, Adults, Geriatric)
7.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Probiotics Dietary Supplements Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Form
7.3.1.2.2. By End-use
7.3.1.2.3. By Applications
7.3.2. United Kingdom Probiotics Dietary Supplements Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Form
7.3.2.2.2. By End-use
7.3.2.2.3. By Applications
7.3.3. France Probiotics Dietary Supplements Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Form
7.3.3.2.2. By End-use
7.3.3.2.3. By Applications
7.3.4. Italy Probiotics Dietary Supplements Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Form
7.3.4.2.2. By End-use
7.3.4.2.3. By Applications
7.3.5. Spain Probiotics Dietary Supplements Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Form
7.3.5.2.2. By End-use
7.3.5.2.3. By Applications
8. ASIA-PACIFIC PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
8.2.2. By End-use (Infants, Children, Adults, Geriatric)
8.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Probiotics Dietary Supplements Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Form
8.3.1.2.2. By End-use
8.3.1.2.3. By Applications
8.3.2. Japan Probiotics Dietary Supplements Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Form
8.3.2.2.2. By End-use
8.3.2.2.3. By Applications
8.3.3. India Probiotics Dietary Supplements Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Form
8.3.3.2.2. By End-use
8.3.3.2.3. By Applications
8.3.4. Australia Probiotics Dietary Supplements Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Form
8.3.4.2.2. By End-use
8.3.4.2.3. By Applications
8.3.5. South Korea Probiotics Dietary Supplements Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Form
8.3.5.2.2. By End-use
8.3.5.2.3. By Applications
9. SOUTH AMERICA PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
9.2.2. By End-use (Infants, Children, Adults, Geriatric)
9.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Probiotics Dietary Supplements Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Form
9.3.1.2.2. By End-use
9.3.1.2.3. By Applications
9.3.2. Argentina Probiotics Dietary Supplements Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Form
9.3.2.2.2. By End-use
9.3.2.2.3. By Applications
9.3.3. Colombia Probiotics Dietary Supplements Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Form
9.3.3.2.2. By End-use
9.3.3.2.3. By Applications
10. MIDDLE EAST AND AFRICA PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
10.2.2. By End-use (Infants, Children, Adults, Geriatric)
10.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Probiotics Dietary Supplements Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Form
10.3.1.2.2. By End-use
10.3.1.2.3. By Applications
10.3.2. Saudi Arabia Probiotics Dietary Supplements Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Form
10.3.2.2.2. By End-use
10.3.2.2.3. By Applications
10.3.3. UAE Probiotics Dietary Supplements Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Form
10.3.3.2.2. By End-use
10.3.3.2.3. By Applications
10.3.4. Kuwait Probiotics Dietary Supplements Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Form
10.3.4.2.2. By End-use
10.3.4.2.3. By Applications
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. Vitakem Nutraceutical Inc
14.1.1. Business Overview
14.1.2. Product & Service Offerings
14.1.3. Recent Developments
14.1.4. Financials (If Listed)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Lesaffre International Corp
14.3. DuPont de Nemours Inc
14.4. H&H Group PLC
14.5. Amway Corp
14.6. Abbott Laboratories Inc
14.7. Bayer AG
14.8. Pfizer Inc.
14.9. GSK PLC
14.10. BASF SE
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
5.2.2. By End-use (Infants, Children, Adults, Geriatric)
5.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Product Market Map
6. NORTH AMERICA PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
6.2.2. By End-use (Infants, Children, Adults, Geriatric)
6.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Probiotics Dietary Supplements Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Form
6.3.1.2.2. By End-use
6.3.1.2.3. By Applications
6.3.2. Canada Probiotics Dietary Supplements Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Form
6.3.2.2.2. By End-use
6.3.2.2.3. By Applications
6.3.3. Mexico Probiotics Dietary Supplements Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Form
6.3.3.2.2. By End-use
6.3.3.2.3. By Applications
7. EUROPE PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
7.2.2. By End-use (Infants, Children, Adults, Geriatric)
7.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Probiotics Dietary Supplements Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Form
7.3.1.2.2. By End-use
7.3.1.2.3. By Applications
7.3.2. United Kingdom Probiotics Dietary Supplements Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Form
7.3.2.2.2. By End-use
7.3.2.2.3. By Applications
7.3.3. France Probiotics Dietary Supplements Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Form
7.3.3.2.2. By End-use
7.3.3.2.3. By Applications
7.3.4. Italy Probiotics Dietary Supplements Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Form
7.3.4.2.2. By End-use
7.3.4.2.3. By Applications
7.3.5. Spain Probiotics Dietary Supplements Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Form
7.3.5.2.2. By End-use
7.3.5.2.3. By Applications
8. ASIA-PACIFIC PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
8.2.2. By End-use (Infants, Children, Adults, Geriatric)
8.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Probiotics Dietary Supplements Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Form
8.3.1.2.2. By End-use
8.3.1.2.3. By Applications
8.3.2. Japan Probiotics Dietary Supplements Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Form
8.3.2.2.2. By End-use
8.3.2.2.3. By Applications
8.3.3. India Probiotics Dietary Supplements Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Form
8.3.3.2.2. By End-use
8.3.3.2.3. By Applications
8.3.4. Australia Probiotics Dietary Supplements Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Form
8.3.4.2.2. By End-use
8.3.4.2.3. By Applications
8.3.5. South Korea Probiotics Dietary Supplements Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Form
8.3.5.2.2. By End-use
8.3.5.2.3. By Applications
9. SOUTH AMERICA PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
9.2.2. By End-use (Infants, Children, Adults, Geriatric)
9.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Probiotics Dietary Supplements Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Form
9.3.1.2.2. By End-use
9.3.1.2.3. By Applications
9.3.2. Argentina Probiotics Dietary Supplements Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Form
9.3.2.2.2. By End-use
9.3.2.2.3. By Applications
9.3.3. Colombia Probiotics Dietary Supplements Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Form
9.3.3.2.2. By End-use
9.3.3.2.3. By Applications
10. MIDDLE EAST AND AFRICA PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
10.2.2. By End-use (Infants, Children, Adults, Geriatric)
10.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Probiotics Dietary Supplements Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Form
10.3.1.2.2. By End-use
10.3.1.2.3. By Applications
10.3.2. Saudi Arabia Probiotics Dietary Supplements Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Form
10.3.2.2.2. By End-use
10.3.2.2.3. By Applications
10.3.3. UAE Probiotics Dietary Supplements Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Form
10.3.3.2.2. By End-use
10.3.3.2.3. By Applications
10.3.4. Kuwait Probiotics Dietary Supplements Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Form
10.3.4.2.2. By End-use
10.3.4.2.3. By Applications
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. Vitakem Nutraceutical Inc
14.1.1. Business Overview
14.1.2. Product & Service Offerings
14.1.3. Recent Developments
14.1.4. Financials (If Listed)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Lesaffre International Corp
14.3. DuPont de Nemours Inc
14.4. H&H Group PLC
14.5. Amway Corp
14.6. Abbott Laboratories Inc
14.7. Bayer AG
14.8. Pfizer Inc.
14.9. GSK PLC
14.10. BASF SE
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
